New Key Statistics Module, Z-Score and F-Score
NAS:ABCL Key Ratios
| Market Cap $ M | 889.05 |
| Enterprise Value $ M | 317.31 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.82 |
| Price/Sales | 26.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 32.00 |
| EPS (TTM) $ | -0.61 |
| Beneish M-Score | -3.01 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.08 |
| EV-to-EBITDA | -1.57 |
| PEG | -- |
| Shares Outstanding M | 295.37 |
| Net Margin (%) | -533.32 |
| Operating Margin % | -893.77 |
| Pre-tax Margin (%) | -613.32 |
| Quick Ratio | 9.34 |
| Current Ratio | 9.34 |
| ROA % (ttm) | -12.09 |
| ROE % (ttm) | -15.55 |
| ROIC % (ttm) | -38.15 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.96 |
ABCL Number of Guru Trades
ABCL Volume of Guru Trades
Gurus Latest Trades with NAS:ABCL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABCL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AbCellera Biologics Inc Insider Transactions
No Available Data
News about NAS:ABCL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers